Used as a chiral intermediate in the synthesis of pharmaceutical compounds, particularly in the development of active pharmaceutical ingredients (APIs) requiring high enantiomeric purity. Its structure supports the formation of complex nitrogen-containing molecules, making it valuable in medicinal chemistry for central nervous system agents, receptor agonists, or antagonists. Commonly employed in asymmetric synthesis due to the stability of the tert-butyl carbamate protecting group, allowing selective functionalization at other sites in the molecule. Also utilized in research settings for generating compound libraries in drug discovery programs.